Program for Appropriate Technology in Health’s (PATH) | Ghana
$99,793 | Stage 1: Proof of Concept | Global Health
Every four minutes, a new mother dies of postpartum hemorrhage. With deaths totaling 140,000 per year worldwide, it is the leading cause of maternal mortality. There is a need to develop and test an affordable, life-saving balloon tamponade that could help combat the leading cause of maternal mortality.
DIV is supporting the Program for Appropriate Technology in Health’s (PATH) development of a safe, simple balloon tamponade that would be affordable in the developing world. The tamponade stops hemorrhage and controls uterine bleeding at as much as a 97% reduction in cost. Balloon tamponades can save a woman’s life 76% to 100% of the time, depending on the design. However, with current costs of up to $312 for a single-use tamponade, they are prohibitively expensive for widespread use in developing countries.
PATH will develop and field test in Ghana an affordable balloon tamponade that costs less than $10, compared to current models used in developed countries that cost between $77 and $312.
Click here to read the project's original press release.
Last updated: July 24, 2013